Abbott's India Plunge May Fetch Big Returns, But Integration Challenges, Growth Momentum Critical
This article was originally published in The Pink Sheet Daily
Executive Summary
Piramal Healthcare Chairman Ajay Piramal talks about the Indian pharmaceutical market after selling his domestic branded generics business to Abbott.